Newswire
ภาษาไทย
English-
CISION PR Newswire - Huawei Unveils Flagship IdeaHub ES3/S3, Bringing A...
BARCELONA, Spain, March 10, 2025 /PRNewswire/ -- During the MWC Barcelona 2025, at the Huawei Intelligent Collaboration Forum themed "Embracing a Smarter Future with Boundless Collaboration", Huawei u... -
CISION PR Newswire - HÄAGEN-DAZS CELEBRATES FIVE TRAILBLAZING WOMEN AS ...
In celebration of International Women's Day, Häagen-Dazs has named Philomena Nwajagu, Faith Ida, Lorna Phillip, Dr Nirja Joshi and Judit Giró Benet the five winners of The Rose Project, Class ... -
CISION PR Newswire - Market Needs a Stronger Boost than Trump's Crypto ...
DUBAI, UAE, March 10, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, released the latest weekly crypto derivatives analytics report with Block... -
CISION PR Newswire - Appian Unveils Latest Platform Release for Faster,...
SYDNEY, March 10, 2025 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced the latest version of the Appian Platform, which delivers improved scalability, speed, and performance for enterpris... -
CISION PR Newswire - HKA WELCOMES FORENSIC ACCOUNTING EXPERT JACQUELINE...
SYDNEY, March 10, 2025 /PRNewswire/ -- HKA, a leading global consultancy in risk mitigation and dispute resolution, is excited to announce that Jacqueline Woods has joined its rapidly expanding... -
CISION PR Newswire - Webull Singapore launches trading competition for ...
SINGAPORE, March 10, 2025 /PRNewswire/ -- Webull Securities (Singapore) Pte Ltd ("Webull Singapore"), a subsidiary of Webull Corporation, a leading digital investment platform, has officially l... -
CISION PR Newswire - RiboX Therapeutics Announces First Patient Dosed i...
PRINCETON, N.J., March 10, 2025 /PRNewswire/ -- RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing fully engineered circular RNA therapeutic... -
CISION PR Newswire - China Telecom and Partners Innovate Together! 5G U...
HONG KONG, March 10, 2025 /PRNewswire/ -- On March 5, during the 2025 Mobile World Congress (MWC25), the 5G UAV medical delivery network solution jointly developed by China Telecom, Hangzhou Antwork N... -
CISION PR Newswire - AIM Vaccine's Iteratively Upgraded Diploid Rabies ...
HONG KONG, March 10, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 9, 2025, the company's research and development of a diplo... -
CISION PR Newswire - U.S. FDA approves Celltrion's OMLYCLO® (omalizumab...
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating com...
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ELITE Beauty.